investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Interplay Between Tissue Architecture and Nuclear Organization in the DNA Damage
Pierre-Alexandre Vidi
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Lisa Wiesmuller
University Hospital Ulm
Ulm, Germany
Pierre-Alexandre Vidi
Wake Forest University
Winston-Salem, United States
Related projects
Ryan Alexander Flynn
CONTROL OF TRANSCRIPTION BY THE 7SK RNA IN BREAST CANCER
Breast
Dario Marchetti
Functional characterization of brain-colonizing breast cancer CTC subsets
Breast
Dezheng Huo
Epidemiological Study of Breast Cancer in Uganda and Cameroon
Breast
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Breast
Donald W. Kufe
Oncogenic Signaling by DF3/MUC1 in Human Breast Cancer
Breast
Tim Greten
Analysis of Cancer-Related Immune Suppressor Mechanisms in Mice
Breast
Fariba Behbod
Elucidating Cellular Heterogeneity Among Cancer Stem Cells by Raman Spectroscopy
Breast
Radiation Oncology
Thomas Westbrook
Discovering Genetic Networks of Triple-Negative Breast Cancer
Breast
Powel Brown
VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST
Breast